An experimental device developed by Cognito Therapeutics seeks to slow cognitive decline in Alzheimer’s patients using light and sound.

About Cognito Therapeutics Cognito Therapeutics is a clinical-stage neurotechnology company developing disease-modifying therapeutic approaches to treat neurodegenerative disorders.

Cognito Therapeutics just raised $73 million to test its headset in 500 patients with Alzheimer's disease.

Cognito Entertainment is an all-new production company centered around science formulated by two producers and a neuroscientist.